Cigna Denied Your Weight Loss Medication? How to Appeal

Cigna denies weight loss medication claims — including Ozempic, Wegovy, and Mounjaro — at high rates, citing BMI thresholds, step therapy requirements, formulary restrictions, and plan exclusions. The American Medical Association recognized obesity as a chronic disease in 2013, and GLP-1 receptor agonists represent FDA-approved medical treatment for it. Understanding Cigna's specific coverage policy and the legal tools available to challenge a denial provides a direct path to an effective appeal.

Why Insurers Deny Weight Loss Medication Claims

Cigna governs weight loss and obesity treatment coverage through Clinical Policy Bulletin (CPB) 0618, publicly available at cigna.com/healthcare-professionals.

BMI criteria not met. CPB 0618 requires a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity (type 2 diabetes, hypertension, hyperlipidemia, obstructive sleep apnea, or cardiovascular disease). If your BMI or comorbidity documentation is missing from submitted records, Cigna will deny on documentation grounds even if you clinically qualify.

Step therapy requirements not satisfied. CPB 0618 typically requires documented failure of physician-supervised weight loss interventions before authorizing GLP-1 receptor agonists. Cigna requires specific documented attempts — not vague references to "diet and exercise." Most state step therapy laws require insurers to grant exceptions when required prior medications are contraindicated or clinically inappropriate.

Plan exclusion of weight loss medications. Some employer plans categorically exclude weight loss drugs. This is a plan design choice, not a clinical determination. Under ERISA, you can challenge whether this exclusion violates the ACA's essential health benefits requirements for your plan type, or raise the issue with HR at open enrollment.

Off-label prescribing. Ozempic (semaglutide 0.5 to 2mg) is FDA-approved for type 2 diabetes, not obesity. When prescribed to a non-diabetic patient for weight loss, Cigna will typically deny. Wegovy (semaglutide 2.4mg) is FDA-approved specifically for chronic weight management and is the appropriate medication to request for obesity treatment.

Formulary tier or step therapy. Even when weight loss medications are covered, Cigna may require failure on lower-tier agents first (metformin, orlistat, phentermine) before authorizing a GLP-1. Step therapy exception requests are available when prior medications are clinically contraindicated.

How to Appeal

Step 1: Request CPB 0618 and Your Plan's Pharmacy Formulary

Identify exactly which medications are covered and under what tier and Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization criteria. Compare the denial reason against CPB 0618's specific requirements.

Step 2: Have Your Prescribing Physician Write a Detailed Letter

The letter must address each CPB 0618 criterion: BMI documentation with date of measurement, comorbidities with supporting lab results (HbA1c, fasting glucose, lipid panel, blood pressure measurements), and clinical rationale for why the specific medication is indicated for your case.

Step 3: Document Prior Treatment History Comprehensively

Specific dates, program names, attendance records, weight progression, and clinical notes are required. Vague references will not satisfy CPB 0618. If prior medications were tried, document dates, dosages, duration, and specific reasons for discontinuation or inadequate response.

Step 4: File a Level 1 Internal Appeal Within 180 Days

Include all clinical documentation and directly address each reason cited in the denial. Cite the FDA approval for the specific medication prescribed and Obesity Medicine Association or ASMBS clinical guidelines supporting treatment for patients with your BMI and comorbidity profile.

Step 5: Request a Peer-to-Peer Review

Have your physician request a direct conversation with Cigna's pharmacy reviewer. This is often the most efficient pathway to authorization for GLP-1 medications, particularly when cardiovascular risk factors beyond weight loss are part of the clinical picture.

Step 6: Request a Step Therapy Exception if Applicable

If Cigna requires you to fail additional medications your physician believes are medically contraindicated or clinically inappropriate, your physician should document this specifically in a step therapy exception request. Most state step therapy laws provide for exceptions when required prior medications pose safety risks.

What to Include in Your Appeal

• CPB 0618 from cigna.com/healthcare-professionals, with the specific criterion at issue identified
• Current height, weight, and calculated BMI from physician records with date of measurement
• Lab results documenting comorbidities: HbA1c, fasting glucose, lipid panel, blood pressure measurements
• Records of physician-supervised weight loss program participation with specific dates, program names, attendance records, weight measurements over time, and dietary/exercise counseling notes
• Prior medication trial records if applicable — dates, dosages, duration, and specific reasons for discontinuation or inadequate response
• Prescribing physician's letter addressing each CPB 0618 criterion directly

Fight Back With ClaimBack

Cigna weight loss medication denials are often reversible when the medical record clearly documents BMI criteria, comorbidities, and prior treatment history matching CPB 0618 requirements. The FDA approval of semaglutide 2.4mg for chronic weight management, combined with the AMA's recognition of obesity as a chronic disease, makes these denials particularly challengeable when the documentation is in order. ClaimBack generates a professional appeal letter in 3 minutes that directly addresses each CPB 0618 criterion in your specific case.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal